We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$2.11B
AUM Growth
+$194M
Cap. Flow
+$818M
Cap. Flow %
38.75%
Top 10 Hldgs %
58.11%
Holding
879
New
298
Increased
119
Reduced
90
Closed
306

Sector Composition

Rank Sector Weight
1 Healthcare 15.03%
2 Consumer Discretionary 11.05%
3 Financials 5.53%
4 Technology 3.61%
5 Industrials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOEV
551
CALL
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$4K ﹤0.01%
127
+3
+2% +$10.7K
CHNG
552
CALL
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$4K ﹤0.01%
+41,300
New +$901K
ACAD icon
553
CALL
Acadia Pharmaceuticals
ACAD
$5.06B
$3K ﹤0.01%
+15,000
New +$289K
APLS
554
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$3K ﹤0.01%
57,800
+27,500
+91% +$1.55M
FITB
555
PUT
Fifth Third Bancorp
FITB
$51.8B
$3K ﹤0.01%
20,000
DFTX
556
CALL
Definium Therapeutics
DFTX
$5.99B
$3K ﹤0.01%
+2,680
New +$116K
SUNL
557
CALL
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$3K ﹤0.01%
+1,125
New +$159K
RDUS
558
CALL
DELISTED
Radius Health, Inc.
RDUS
$3K ﹤0.01%
7,500
TRIL
559
CALL
DELISTED
Trillium Therapeutics Inc.
TRIL
$3K ﹤0.01%
+121,600
New +$1.42M
CERS icon
560
CALL
Cerus
CERS
$508M
$2K ﹤0.01%
12,200
EDIT icon
561
CALL
Editas Medicine
EDIT
$432M
$2K ﹤0.01%
+34,800
New +$1.91M
RIGL icon
562
CALL
Rigel Pharmaceuticals
RIGL
$778M
$2K ﹤0.01%
1,000
-1,450
-59% -$57.1K
SAND
563
CALL
DELISTED
Sandstorm Gold
SAND
$2K ﹤0.01%
28,300
ZNTL icon
564
CALL
Zentalis Pharmaceuticals
ZNTL
$297M
$2K ﹤0.01%
+16,000
New +$923K
CBAY
565
CALL
DELISTED
Cymabay Therapeutics
CBAY
$2K ﹤0.01%
67,300
-1,200
-2% -$4.73K
SDC
566
PUT
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$2K ﹤0.01%
+80,300
New +$499K
HAAC
567
CALL
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$2K ﹤0.01%
+99,100
New +$970K
ASHR icon
568
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
$1K ﹤0.01%
+10,000
New +$386K
BMY icon
569
CALL
Bristol-Myers Squibb
BMY
$132B
$1K ﹤0.01%
+20,000
New +$1.32M
FXI icon
570
PUT
iShares China Large-Cap ETF
FXI
$4.35B
$1K ﹤0.01%
6,800
-306,800
-98% -$12.7M
ZNTL icon
571
PUT
Zentalis Pharmaceuticals
ZNTL
$297M
$1K ﹤0.01%
+300
New +$17.3K
DSPG
572
CALL
DELISTED
DSP Group Inc
DSPG
$1K ﹤0.01%
+10,000
New +$179K
ABBV icon
573
CALL
AbbVie
ABBV
$438B
-40,000
Closed -$76K
ACB
574
CALL
Aurora Cannabis
ACB
$179M
-22,640
Closed -$25K
ACRS icon
575
CALL
Aclaris Therapeutics
ACRS
$868M
-55,300
Closed -$47K

Similar funds

Cowen and Company's Q3 2021 Portfolio in Review

As of Q3 2021, Cowen and Company held 879 positions worth $2.11B, up 10% from $1.92B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Cowen and Company deployed $818M of net new capital in Q3 2021, opening 298 new positions and adding to 119 existing holdings. Its largest new stake was Macquarie Infrastructure Holdings, LLC: 1,190,000 shares worth $48.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Nice, an estimated $7.38M trimmed.

  • Cowen and Company's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 1,190,000 shares worth $48.3M.
  • Cowen and Company added most to FTAI Aviation in Q3 2021, an estimated $42.9M increase.
  • Cowen and Company's biggest Q3 2021 reduction was Nice, cutting an estimated $7.38M.
  • Cowen and Company fully exited Foley Trasimene Acquisition Corp. in Q3 2021, selling an estimated $15.1M.
  • Cowen and Company's ten largest holdings make up 58% of its $2.11B portfolio in Q3 2021.
  • Cowen and Company opened 298 new positions and closed 306 in Q3 2021.
  • Cowen and Company's portfolio value rose 10% quarter-over-quarter to $2.11B.

Based on Cowen and Company's 13F filing for Q3 2021, filed 12 Nov 2021.